1. Volume 379, Issue 9816, Pages 641-647 (February 2012)
Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials 
Dr Christine Johnston, MD, Misty Saracino, PhD, Steve Kuntz, PA-C, Amalia Magaret, PhD, Stacy Selke, MS, Meei-li Huang, PhD, Joshua T Schiffer, MD, Prof David M Koelle, MD, Prof Lawrence Corey, MD, Prof Anna Wald, MD 
The Lancet 
Volume 379, Issue 9816, Pages (February 2012)
DOI: /S (11)
Copyright © 2012 Elsevier Ltd Terms and Conditions

2. Figure 1
Trial profiles
The Lancet  , DOI: ( /S (11) )
Copyright © 2012 Elsevier Ltd Terms and Conditions

3. Figure 2 HSV detection in genital swabs
Error bars are the 95% CIs. AUCs taken from Reitano and colleagues6 and Beutner and colleagues.17 IRR=incidence risk ratio. AUC=area under the curve (μg × h per mL).
The Lancet  , DOI: ( /S (11) )
Copyright © 2012 Elsevier Ltd Terms and Conditions